Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis

Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141B(5):482-6. doi: 10.1002/ajmg.b.30337.

Abstract

The role of the delta-opioid receptor (OPRD1) in methamphetamine (MAP) addiction was investigated using association analysis between OPRD1 gene polymorphisms and MAP dependence/psychosis. DNA samples from Japanese patients with MAP dependence/psychosis were analyzed to find polymorphisms in OPRD1 gene exons and exon-intron boundaries. One novel single nucleotide polymorphism (SNP) in intron 1 and two SNPs in exon 3 were identified. The two SNPs in exon 3 were in linkage disequilibrium. No significant difference was observed in either genotypic or allelic frequencies of these SNPs between controls (n = 260) and MAP dependent/psychotic patients (n = 170). Global analyses using the three SNPs and subcategory analyses on clinical parameters also showed no significant differences. These results suggest that the OPRD1 gene variants may not be a factor in vulnerability to MAP dependence/psychosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Humans
  • Japan
  • Linkage Disequilibrium
  • Male
  • Methamphetamine*
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Psychoses, Substance-Induced / genetics*
  • Receptors, Opioid, delta / genetics*

Substances

  • Receptors, Opioid, delta
  • Methamphetamine